Cargando…

Drosophila PRL-1 Is a Growth Inhibitor That Counteracts the Function of the Src Oncogene

Phosphatase of Regenerating Liver (PRL) family members have emerged as molecular markers that significantly correlate to the ability of many cancers to metastasize. However, contradictory cellular responses to PRL expression have been reported, including the inhibition of cell cycle progression. An...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pagarigan, Krystle T., Bunn, Bryce W., Goodchild, Jake, Rahe, Travis K., Weis, Julie F., Saucedo, Leslie J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620046/ https://www.ncbi.nlm.nih.gov/pubmed/23577193 http://dx.doi.org/10.1371/journal.pone.0061084

Ejemplares similares

Src-Mediated Phosphorylation of the Tyrosine Phosphatase PRL-3 Is Required for PRL-3 Promotion of Rho Activation, Motility and Invasion
por: Fiordalisi, James J., et al.
Publicado: (2013)

Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity
por: Gehring, Kalle, et al.
Publicado: (2020)

Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
por: Radke, I, et al.
Publicado: (2006)

Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma
por: Jin, Shaowen, et al.
Publicado: (2014)

Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia
por: Park, Jung Eun, et al.
Publicado: (2013)

Methionine restriction breaks obligatory coupling of cell proliferation and death by an oncogene Src in Drosophila
por: Nishida, Hiroshi, et al.
Publicado: (2021)

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Thura, Min, et al.
Publicado: (2019)

MTH1 counteracts oncogenic oxidative stress
por: Burton, Dominick G.A., et al.
Publicado: (2015)

Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Thura, Min, et al.
Publicado: (2021)

Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD–negative acute myeloid leukemia
por: Qu, Shuang, et al.
Publicado: (2014)

Src Cooperates with Oncogenic Ras in Tumourigenesis via the JNK and PI3K Pathways in Drosophila epithelial Tissue
por: Poon, Carole L.C., et al.
Publicado: (2018)

Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer
por: Ooki, Akira, et al.
Publicado: (2011)

Analysis of molecular determinants of PRL-3
por: Pascaru, Mihaela, et al.
Publicado: (2009)

PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse
por: Thura, Min, et al.
Publicado: (2021)

Historical retrospective of the SRC oncogene and new perspectives (Review)
por: Simatou, Aristofania, et al.
Publicado: (2020)

Loss of the oncogenic phosphatase PRL-3 promotes a TNF-R1 feedback loop that mediates triple-negative breast cancer growth
por: Gari, H H, et al.
Publicado: (2016)

Depletion of Tissue-Specific Ion Transporters Causes Differential Expression of PRL Targets in Response to Increased Levels of Endogenous PRL
por: Shu, Tingting, et al.
Publicado: (2018)

MiR-130a-3p Inhibits PRL Expression and Is Associated With Heat Stress-Induced PRL Reduction
por: Zhang, Haojie, et al.
Publicado: (2020)

PRL-3 exerts oncogenic functions in myeloid leukemia cells via aberrant dephosphorylation of stathmin and activation of STAT3 signaling
por: Xu, Jianping, et al.
Publicado: (2019)

Generation of conditional knockout alleles for PRL-3()
por: Yan, Hong, et al.
Publicado: (2011)

The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042
por: Hermida-Prado, Francisco, et al.
Publicado: (2019)

Author Correction: PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse
por: Thura, Min, et al.
Publicado: (2021)

EPS8 phosphorylation by Src modulates its oncogenic functions
por: Shahoumi, Linah A., et al.
Publicado: (2020)

The potential of Src inhibitors
por: Elias, Daniel, et al.
Publicado: (2015)

Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody
por: Loh, Amos Hong Pheng, et al.
Publicado: (2023)

Fanconi anemia proteins counteract the implementation of the oncogene-induced senescence program
por: Helbling-Leclerc, Anne, et al.
Publicado: (2019)

Proto-oncogene tyrosine-protein kinase SRC (Src) inhibition in microglia relieves neuroinflammation in neuropathic pain mouse models
por: Cai, Yuanxing, et al.
Publicado: (2021)

Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL
por: Alam, Zohaib, et al.
Publicado: (2015)

Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3
por: Rubio, Teresa, et al.
Publicado: (2016)

PRL-3 promotes telomere deprotection and chromosomal instability
por: Lian, Shenyi, et al.
Publicado: (2017)

Binocularity Principles of PRL Development in Patients With Macular Disease
por: Tarita-Nistor, Luminita, et al.
Publicado: (2022)

H-Ras oncogene counteracts the growth-inhibitory effect of genistein in T24 bladder carcinoma cells
por: Li, C, et al.
Publicado: (2005)

Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers
por: Gari, Hamid H., et al.
Publicado: (2016)

Anti-PRL-3 Monoclonal Antibody inhibits the Growth and Metastasis of colorectal adenocarcinoma
por: Sun, Shuning, et al.
Publicado: (2023)

A FRET-based screening method to detect potential inhibitors of the binding of CNNM3 to PRL2
por: Cai, Faji, et al.
Publicado: (2020)

Production of Murine Leukemia RL♂1 Rejection Antigen Peptide pRL1a by Proteolysis of Natural Precursor pRL1b
por: Ono, Toshiro, et al.
Publicado: (1996)

Return to Play in Athletes Receiving Cervical Surgery: A Systematic Review
por: Molinari, Robert W., et al.
Publicado: (2016)

Wash functions downstream of Rho1 GTPase in a subset of Drosophila immune cell developmental migrations
por: Verboon, Jeffrey M., et al.
Publicado: (2015)

parkin counteracts symptoms in a Drosophila model of Parkinson's disease
por: Haywood, Annika FM, et al.
Publicado: (2004)

Active Rho is localized to podosomes induced by oncogenic Src and is required for their assembly and function
por: Berdeaux, Rebecca L., et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_oebn1gm5cpj9o730hdkvcm14b5